Neeraj Adya
Immunology & Diagnostic Development Leader Johnson & Johnson
A Precision Medicine Diagnostic (PMDx) leader with over 25 years of experience in In-Vitro Diagnostics (IVD) and Companion Diagnostic development. Currently leading the PMDx team within Johnson & Johnson Immunology towards identifying and implementing the right diagnostic solutions in clinical trials and strategically positioning for delivery of diagnostic (Dx)/companion-diagnostic (CDx) where needed. Prior to J&J led teams in developing and delivering Dx/CDx strategies across areas of oncology, immune-oncology, immunology, cardiovascular, and fibrosis. What excites me is the opportunity to use novel and innovative precision medicine tools in expediting efficacious drug development for patients.
Seminars
- Discuss Precision Medicine opportunities for in IBD using predictive and prognostic biomarkers, drawing parallels with immunology and Oncology programs advancing into later trials
- Unpack the gap between translational biomarker insights and real-world diagnostics, including regulatory, commercial, and scalability hurdlesDiscuss challenges in moving from translation level biomarker insights to clinically validated tools
